The Highwire with Del Bigtree - FDA APPROVES 5TH COVID BOOSTER

Episode Date: April 8, 2022

Public trust in the agencies behind the COVID booster push have suffered massively from continually making recommendations outside data and sound science. The FDA’s latest move to push 4th and 5th boosters may be the final straw for a medical community already up in arms.#Boosters #FDA #PeterMarksBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

It's booster season again, booster mania. At the Highwire here, we report on the story as it was breaking at the highwire.com news section. FDA authorizes fourth, fifth booster doses for various groups and ages, bypasses expert vote. What they did was they allowed what they called a second booster of Pfizer-Mordera for 50 and overs. They allowed Pfizer booster, a second booster. I should say this is their language of Pfizer for 12 and over immunocompromised and a second booster for 18 and overs for moderna now what's interesting about this um was the the the science and the medical community has already been in an upward reported on this since basically eight months since august since the first

boosters being rolling out they continually bypass this committee and has been no different this time johns hopkins marty mccari he's a surgeon public policy researcher at the university he took to twitter and just blasted the cdc and the fda there is zero clinical data that a fourth dose reduces hospitalization risk, he writes. There isn't even any evidence that a third dose reduces hospitalization risk in young people. He goes on to say political interference over boosters was the issue behind two high-level FDA departures in the fall. There is no greater slap in the face of science than bypassing the customary FDA external expert voting process over an authorization with insufficient supporting clinical data. And what is he talking about? Well, on August 18th,

2021, the Biden administration during the first booster push unilaterally announced boosters before the CDC ASEP committee, the advisory committee, even met to talk about them, even met to go over the science. They just unilaterally did it. And what happened right after that was this headline. This is what Marty McCarrey is talking about. Top FDA vaccine officials to leave agency as decision on COVID boosters looms. This is Marion Gruber, Philip Cruz at the time. We talked about this. These were the two veteran vaccine researchers, decades of experience between them. They unexpectedly, unexpectedly left at the time. Now we know it was over this booster push with insufficient data. So now that's bringing us right back. You know what's really terrifying to me right now.

And I just made this connection after talking to Amy Bond about you have the bill that's trying to, you know, bring back the vaccination for children. It's trying to get rid of informed consent of what she was discussing and using the bill using law enforcement to work for the health department. But what she's, you know, she's saying is they want the right in California. They're trying to give the health department in California the right to override legislators, that there will be no more legislation involved in future vaccine decisions, that the vaccines will just be decided everyone by the health department if they want to add a booster. And by saying whatever the FDA or CDC recommends,

we could go with that, even if they didn't speak to the vaccine data group or ASIP. So what you're seeing is there's a line being drawn straight from whatever. globalist power system of the medical establishment right into our bodies without any interference. There's going to be no legislation interference is what they want. They don't even want to have the emergency use authorization standing in their way. If someone inside the FDA overrides all of the panels and groups, professional groups they normally relate to and say, hey, we're going with it because I work for Merck and that's that's what we're going with or I used to work for Moderna. And I'm pushing this thing ahead. I believe in it personally. No professional groups,

no EUA, straight to whoever wants it. The Health Department of California and other states just say, there it is. No legislators can get involved. Do you see how terrifying? They're just creating a direct line from pharma straight into our bodies with no ability to interject any legislators. And then if we stand up and complain about it, we're censored. If we actually walk down the street without it, they're going to use the law enforcement

like military to like kick in our doors and arrest us. I mean, these people are freaking crazy. And a lot of the commentary out there right now is saying, well, how can the CDC and the FDA gain back to public trust? They really lost it here. But no one's really talking about what's happening right now and saying about this, like you said, these lack, their complete loss of medical checks and balance, medical lawlessness, if you will. Let's go to the FDA's press release. So again, they bypassed their Verbat committee.

Their expert voting panel is the independent panel of experts. They just didn't even care to consult them. They gave us a press release. Here it is. March 29th, FDA authorized a second booster. So they're calling it second booster dose. And this starts get confusing. We're going to break it down of two COVID-19 vaccines.

That's Pfizer-Moderna for older and immunocompromised individuals. And it says in there, the FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccine vaccination series. Hold on. I thought it was a two-dose series. So they're saying in here three-dose series. They go on to say this action will now make a second booster dose. So that would be number five if anybody's counting.

of these vaccines available for other populations at higher risk for severe disease hospitalization and death. When did three end up becoming like the standard? I mean, like you said, when we see fully vaccinated, that was two. It was a two-dose program. Right, right. And so let's bring it back to that fateful time where Marying Gruber, Phil Cruz, left the agency over the booster decision.

There was this vacuum that was created. A couple days later, there's an ASIP committee meeting, the CDC's ASIP committee, and Stanley Plachin, the godfather of vaccines, we've covered him here so many times. He called into that ASIP meeting. And this is what the article is actually an article at stat news that reported on this, the debate over COVID-19 vaccine boosters, what to call them, and whether they're needed. So he interjected here via a phone call and said this, calling the third dose of booster is immunologically incorrect and also gives the wrong impression

that somehow the vaccines failed when they could not really have been expected to give a long lasting immunity from the first dose, Plotkin said. So that is where this thing really started. It's kind of weaving around there in the background after he's sput that out there. And then it pops through the surface here in this FDA newsletter release. So now we're talking fourth and fifth boosters. And where did the CDC rely on this data from? Well, it says in their own press release, the immunogenicity data,

they took from an ongoing open label, non-randomized, clinical study at one healthcare center in Israel. And what did that look like? Well, here is the actual study. Let's take a look at it. Fourth dose COVID-MRNA vaccine immunogenicity and efficacy against Amicron variant of concern. The authors say breakthrough infections were common, mostly very mild yet with high viral loads.

Get this, vaccine efficacy against the infection was 30% and 11% respectively. That's for 30% percent. for Pfizer, 11% for Moderna. Local and systemic adverse reactions were reported in 80% in Pfizer, 40% respectively in Moderna. So this is what the FDA is relying upon. This is what they used to override having any of the Verbeck, the professional, you know, committee group that was supposed to give their advice or ASIP. They overrode all of those things because of this study that basically says at best you know 30% efficacy and an 80% chance of giving. getting, you know, a mild vaccine injury.

Yeah. And they looked at some of the safety data from the Ministry of Health population coverage in Israel, nothing from America really. And these authors went on to conclude in this study, the fourth COVID-19 MRI dose restores antibody titers to peak post third dose titers. But they also say low efficacy in preventing mild or asymptomatic Omicron infections and the infectious potential of breakthrough cases raise the urgency of next generation vaccine development. And here we are sitting on the cusp, almost a year ago to the day, we had the CDC director,

Rochelle Walensky, go on MSNBC and say that vaccinated people don't carry the virus whatsoever. We've known this was a lie really since then. We covered it then. And it's been a lie. This study continues to say this is a lie with even the boosters. And here we have the lead author of that Israeli study. He's been doing the rounds in the media. This was him on NPR.

He says, this is the headline, who might benefit from a fourth shot and who might not. He says this, not a third dose, not a fourth dose. not a fourth dose, not a fifth dose, will do anything to stop infections long term, says Dr. Gili Rajab Yashay, an infectious disease specialist at Shiba Medical Center in Tal-Hashar Israel, the lead author of the new study. And just to cap off this section, so we were kind of left. This is proof. This is proof that they know nobody reads. No doctor reads, no scientist reads beyond the headline because they put in there, because of this study, we have proved that it works, we're giving a booster shot.

No one's going to read this study. You did. You did. And you found that the lead authors saying, yeah, these things don't work at all. It's not going to stop. You're going to be spreading it everywhere you go. Yet they are so sure that we're that stupid.

We're never going to read that this is what we're basing our information on. Right. And just looking at this, from the FDA standpoint, if you're immunocompromised or even 50 and over, it looks like you are just going to be in line for whatever amount of boosters that they want to give you. That's basically what they're saying. But now, a day after. this FDA press release broke.

We had Peter Marks. He's, the FDA's head for the Center of Biologics evaluation and research. We've had a lot of exchanges with him with our lawyers. And he went on a press media call. Listen to what he had to say about the boosters. Will people be expected to get another booster in the fall or summer if that's frequently? Thanks for reminding me of that part of the question. So there will be a discussion at the vaccine.

Dean's Advisory Committee meeting next week where I think this will be discussed. I should say that it would not be surprising if there is a potential need. I don't want to shock anyone, but there may be a need for people to get an additional booster in the fall along with a more general booster campaign if that takes place, because we may need to shift over to, to a different variant coverage. In other words, it may be that a decision is made that rather than what we currently have, the vaccines we currently have,

which are called vaccines against the prototype virus, that we will move to a vaccine that is either against one of the variants, whether it's Omicron, Theta or Delta, or something else, I can't say right now, that's for discussion, or whether it's some nix of different ones, but it's possible that people will need to get another vaccine there.

And getting this booster will not preclude people from getting that booster necessarily if there's evidence that another booster could be of benefit. Man, I'm telling you, the highway would be half as long if these people can just say exactly what they mean instead of just like drum up this ridiculous word salad. I mean, here's what he's basically saying, yeah, COVID boosters till the end of time, probably every couple of months. We've already given you four or five. We're looking towards six in just the first year.

So what are you think? Of course boosters are coming. Yeah, we're going to try and hit other variants, probably try and pack them all to a vaccine. You know, that probably won't work either. But, you know, I'm supposed to tell you, well, there's a chance there could be a booster. Folks, get ready. If you're already on that conveyor belt, it never ends for you.

Doesn't matter that it doesn't work. They've wiped out your immune system and they have no other plan for you except to keep trying to boost you every couple of days with a brand new product. where they make billions and you get sicker and sicker and sicker. And from my count, that would be six. And he's basically saying, I don't want to shock you, but six are coming and six isn't going to be enough because we have just the prototype strain that we've been vaccinated

you against. We don't have the new variants coming out. Prototype strain, right? I know he doesn't mean that. I'm not going to make a big thing out of it. But aren't we calling that the Wuhan strain or the out, you know, like there's alpha, beta, delta, but the prototype strain, just such an odd use.

such an odd use of language there. Right. And, you know, Dillon, you mentioned about reading these studies, hoping they won't read them. I spoke to our legal team before I went on air. The next installment of the Pfizer documents data dump will be coming tomorrow. We're expecting over 10,000 documents. You can go to I Can Decide.org to get these documents. You can be right alongside us in the investigation here as we look through these and we see what we're going to find.